22.12.2012 Views

Bulletin 2010/15 - European Patent Office

Bulletin 2010/15 - European Patent Office

Bulletin 2010/15 - European Patent Office

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(A61K) I.1(2)<br />

(25) Es (26) En<br />

(21) 08787632.2 (22) 25.06.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(86) ES 2008/000451 25.06.2008<br />

(87) WO 2009/000955 2009/01 31.12.2008<br />

(30) 26.06.2007 ES 200701790<br />

(54) • MIKROPARTIKEL AUS MIT RGD MODIFI-<br />

ZIERTEM ALGINAT ALS SYSTEM ZUR<br />

FREISETZUNG VON MEDIKAMENTEN<br />

• MICROPARTICLES OF ALGINATE MODI-<br />

FIED WITH RGD AS A RELEASE SYSTEM<br />

FOR MEDICINES<br />

• MICROPARTICULES D'ALGINATE MODIFIÉ<br />

À L'AIDE D'UNE SÉQUENCE RGD COMME<br />

SYSTÈME DE LIBÉRATION DE SUBSTAN-<br />

CES PHARMACEUTIQUES<br />

(71) Universidad del Pais Vasco, Barrio Sarriena,<br />

s/n, 48940 Leioa Vizcaya, ES<br />

(72) ORIVE ARROYO, Gorka, E-48940 Leioa, ES<br />

PEDRAZ MUÑOZ, José Luis, E-48940 Leioa,<br />

ES<br />

HERNÁNDEZ MARTÍN, Rosa María, E-48940<br />

Leioa, ES<br />

(74) ABG <strong>Patent</strong>es, S.L., Avenida de Burgos 16D<br />

Edificio Euromor, 28036 Madrid, ES<br />

(51) A61K 9/50 (11) 2 174 657 A1<br />

A23C 9/<strong>15</strong>2 A23L 1/00<br />

A23L 1/304 A61K 33/00<br />

A61P 7/06<br />

(25) En (26) En<br />

(21) 08166052.4 (22) 08.10.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(54) • Eisenhaltiges Produkt in Form von Kapseln<br />

und ihr Herstellungsverfahren<br />

• Iron source product in the form of capsules<br />

and process for their prepartion<br />

• Produit source de fer sous forme de<br />

capsules et son procédé de préparation<br />

(71) AB-Biotics Producciones Industriales De<br />

Microbiotas, S.L., Viver d'Empreses de la<br />

UAB Parc Tecnològic del Vallès Masia Can<br />

Fatjó del Molí, s/n (AB-Biotics), 08290<br />

Cerdanyola del Vallès, ES<br />

(72) Drudis Solé, Galí, 08023, Barcelona, ES<br />

(74) ZBM <strong>Patent</strong>s, Zea, Barlocci & Markvardsen<br />

Plaza Catalunya, 1, 08002 Barcelona, ES<br />

A61K 9/70 → (51) A61K 8/60<br />

(51) A61K 31/34 (11) 2 174 658 A1<br />

A61K 31/502 A61K 31/353<br />

A61P 9/00<br />

(25) En (26) En<br />

(21) 090<strong>15</strong>249.7 (22) 16.11.2005<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

AL BA HR MK YU<br />

(30) 31.05.2005 US 141235<br />

10.11.2005 US 272562<br />

<strong>15</strong>.11.2005 US 273992<br />

(54) • Zusammensetzungen mit Nebivolol<br />

• Compositions comprising nebivolol<br />

• Compositions comportant du nebivolol<br />

(71) MYLAN LABORATORIES, INC, 781 Chestnut<br />

Ridge Road, Morgantown, NV 26504, US<br />

(72) Davis, Eric, Morgantown WV 26508, US<br />

O'Donnell, John, Morgantown WV 26505,<br />

US<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

Bottini, Peter, Bruce, Morgantown WV26505,<br />

US<br />

Mason, Preston, Morgantown WV 26504, US<br />

Shaw, Andrew, Morgantown Wv 26504, US<br />

(74) Samson & Partner, Widenmayerstrasse 5,<br />

80538 München, DE<br />

(62) 05848185.4 / 1 890 691<br />

A61K 31/345 → (51) A61K 9/00<br />

A61K 31/353 → (51) A61K 31/34<br />

A61K 31/382 → (51) C07D 409/04<br />

A61K 31/41 → (51) A61K 45/00<br />

A61K 31/4164 → (51) A61K 9/00<br />

A61K 31/4174 → (51) A61K 9/00<br />

A61K 31/4178 → (51) A61K 45/00<br />

A61K 31/4184 → (51) A61K 45/00<br />

A61K 31/421 → (51) C07D 263/20<br />

(51) A61K 31/435 (11) 2 174 659 A1<br />

A61K 31/473 A61K 31/4741<br />

A61K 31/4743 A61K 31/4745<br />

C07D 221/18 C07D 471/04<br />

C07D 491/04 C07D 495/04<br />

A61P 29/00 A61P 35/00<br />

A61P 3/10<br />

(25) En (26) En<br />

(21) 10<strong>15</strong>2431.2 (22) 30.08.2002<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR IE IT LI LU MC NL PT SE SK TR<br />

LT LV MK RO SI<br />

(30) 31.08.2001 US 944524<br />

(54) • Substituierte Indeno-[1,2-c]-isochinolin-<br />

Derivate und Verwendungszwecke dafür<br />

• Substituted indeno[1,2-c]isoquinoline<br />

derivatives and uses thereof<br />

• Dérivé d'indeno[1,2-c]-isoquinoléine substitutués<br />

et utilisation de ces composés<br />

(71) Inotek Pharmaceuticals Corporation, 100<br />

Cummings Center, Beverly, MA 019<strong>15</strong>, US<br />

(72) Jagtap, Prakash, G., Beverly, MA 019<strong>15</strong>-<br />

1852, US<br />

Baloglu, Erkan, Stoneham, MA 02180, US<br />

Van Fuzer, John, H., Georgetown, MA 01833,<br />

US<br />

Szabo, Csaba, Gloucester, MA 01930, US<br />

Salzman, Andrew, L., Belmont, MA 02078,<br />

US<br />

(74) Elend, Almut Susanne, et al, Venner Shipley<br />

LLP Byron House Cambridge Business Park<br />

Cowley Road, Cambridge CB4 0WZ, GB<br />

(62) 02766175.0 / 1 420 785<br />

A61K 31/4412 → (51) A61K 9/00<br />

A61K 31/4418 → (51) A61K 9/00<br />

A61K 31/454 → (51) A61K 45/00<br />

A61K 31/473 → (51) A61K 31/435<br />

A61K 31/4741 → (51) A61K 31/435<br />

A61K 31/4743 → (51) A61K 31/435<br />

A61K 31/4745 → (51) A61K 9/00<br />

A61K 31/4745 → (51) A61K 31/435<br />

A61K 31/495 → (51) A61P 1/08<br />

222<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>15</strong>/<strong>2010</strong>) 14.04.<strong>2010</strong><br />

A61K 31/502 → (51) A61K 31/34<br />

A61K 31/52 → (51) A61K 8/60<br />

A61K 31/522 → (51) A61K 9/00<br />

A61K 31/522 → (51) A61P 1/08<br />

A61K 31/522 → (51) C07D 277/76<br />

A61K 31/535 → (51) C07D 263/20<br />

A61K 31/55 → (51) C07D 471/14<br />

A61K 31/569 → (51) A61K 9/00<br />

A61K 31/664 → (51) C07D 211/92<br />

A61K 31/704 → (51) A61K 9/06<br />

A61K 31/7048 → (51) C07H 17/08<br />

A61K 31/7076 → (51) A61K 8/60<br />

A61K 31/77 → (51) C08G 65/28<br />

A61K 33/00 → (51) A61K 9/50<br />

A61K 33/24 → (51) A61K 8/27<br />

A61K 33/30 → (51) A61K 8/27<br />

A61K 35/16 → (51) A61M 1/02<br />

A61K 38/00 → (51) C07K 1/02<br />

A61K 38/08 → (51) C07K 16/18<br />

A61K 38/10 → (51) C07K 16/18<br />

A61K 38/11 → (51) A61K 9/08<br />

A61K 38/16 → (51) C07K 14/33<br />

A61K 38/18 → (51) A61L 27/22<br />

(51) A61K 38/22 (11) 2 174 660 A1<br />

A61K 47/42 A61P 43/00<br />

(25) Ja (26) En<br />

(21) 08790688.9 (22) 27.06.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(86) JP 2008/061723 27.06.2008<br />

(87) WO 2009/005000 2009/02 08.01.2009<br />

(30) 29.06.2007 JP 2007171676<br />

(54) • ZUSAMMENSETZUNG ZUR MUKOSALEN<br />

VERABREICHUNG MIT EINEM WIRKSTOFF<br />

ZUR BESCHLEUNIGUNG DER SCHLEIM-<br />

HAUTABSORPTION EINER PEPTIDARZNEI<br />

UND VERFAHREN ZU IHRER VERABREI-<br />

CHUNG<br />

• COMPOSITION FOR MUCOSAL ADMINIS-<br />

TRATION CONTAINING AGENT FOR<br />

ACCELERATING MUCOSAL ABSORPTION<br />

OF PEPTIDE DRUG AND ADMINISTRATION<br />

METHOD THEREOF<br />

• COMPOSITION POUR ADMINISTRATION<br />

MUCOSALE CONTENANT UN AGENT<br />

D'ACCÉLÉRATION D'ABSORPTION MUCO-<br />

SALE DE MÉDICAMENT PEPTIDIQUE ET<br />

SON PROCÉDÉ D'ADMINISTRATION<br />

(71) Asubio Pharma Co., Ltd., 9-11 Akasaka 2chome,<br />

Minato-ku Tokyo 107-8541, JP<br />

(72) KONDOH, Masuo, Ikeda-shi Osaka 563-<br />

0029, JP<br />

UCHIDA, Hiroshi, Ohra-gun Gunma 370-<br />

0503, JP

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!